Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in EuropeElise R. A. Pennings, Yolanda Cabrerizo, Pacôme Lecot et al.|Blood Advances|2025Cited by 3
The European CAR‐T map—Current status and future directions to improve access to CAR T‐cell therapy for hematologic malignanciesElise R. A. Pennings, Marie José Kersten, Frederick W. Thielen et al.|HemaSphere|2026Cited by 2
Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in EuropeDelphine Ammar, Jacquelyn Awigena-Cook, Carmen Sanges et al.|Cytotherapy|2025Cited by 0
The European CAR-T map - Current status and future directions to improve access to CAR T-cell therapy for hematologic malignanciesElise R. A. Pennings, :unav, Frederick W. Thielen et al.|Unknown|2026Cited by 0